Skip to Content
  • Ian Read’s Pfizer Coin

    Via Matthew Herper on Twitter, I see that the Telegraph has this insight into Pfizer’s corporate culture, or at least its upper reaches. CEO Ian Read appa… Read More
  • Sanofi’s Search

    Have you noticed that Sanofi hasn’t named a replacement yet for their ousted CEO Chris Viehbacher? It doesn’t seem to be for lack of trying. Stories… Read More
  • GSK Cuts Back in China (?)

    Here’s a report that GSK is cutting back severely in China – 1,000 workers during the first part of this year. seems to be first out with… Read More
  • A Look At Actavis

    This profile of Actavis CEO Brent Saunders (by Matthew Herper) makes interesting reading, if your definition of “interesting” is roomy enough to tak… Read More
  • Constellation’s Situation

    Constellation Pharmaceuticals of Cambridge, a big player in the epigenetics area, struck a deal with Genentech in 2012. And (faster than anyone thought), itR… Read More
  • Moderna Marches On

    Moderna Therapeutics, the mRNA-based company, is staying busy. They’ve got so much work on their hands that they’re spinning out different therapeut… Read More
  • Geniuses at Pharmacyclics

    Via Adam Feuerstein on Twitter, here’s an odd story about what goes on at Pharmacyclics. CEO Bob Duggan is apparently encouraging the staff there to take… Read More
Page 20 of 103« First...10...1819202122...304050...Last »